Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Larsson

Showing results (271-280 of 316) with videos related to

Pageof 32
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumoursR Larsson, H Fridborg, J Liliemark, et al.
European Journal of Pharmacology|July 4, 1998
Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistanceS Dhar, P Nygren, G Liminga, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Blood|August 26, 1998
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulationB Nilsson, R Larsson, J Hong, et al.
Anticancer Research|September 1, 1993
Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferasesM de la Torre, X Y Hao, R Larsson, et al.
Cancer Research|December 3, 1999
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivoP J Hjarnaa, E Jonsson, S Latini, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in ratsE Jonsson, L E Friberg, M O Karlsson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patientsA Henningsson, A Sparreboom, M Sandström, et al.
Biopharmaceutics & Drug Disposition|November 1, 1995
Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjectorA G Nyberg, G Cassel, T Jeneskog, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Pageof 32

Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumoursR Larsson, H Fridborg, J Liliemark, et al.
European Journal of Pharmacology|July 4, 1998
Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistanceS Dhar, P Nygren, G Liminga, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Blood|August 26, 1998
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulationB Nilsson, R Larsson, J Hong, et al.
Anticancer Research|September 1, 1993
Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferasesM de la Torre, X Y Hao, R Larsson, et al.
Cancer Research|December 3, 1999
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivoP J Hjarnaa, E Jonsson, S Latini, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in ratsE Jonsson, L E Friberg, M O Karlsson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patientsA Henningsson, A Sparreboom, M Sandström, et al.
Biopharmaceutics & Drug Disposition|November 1, 1995
Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjectorA G Nyberg, G Cassel, T Jeneskog, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Pageof 32